Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

Zonalta (Z-endoxifen hydrochloride)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Intas, Jina Pharma, National Cancer Institute

Drug class:

Estrogen receptor antagonist, Selective estrogen receptor modulator

Related drugs:

ER positive	Estrogen Receptor Positive Breast Cancer	ER positive	Estrogen Receptor Positive Breast Cancer	Z-endoxifen hydrochloride Sensitive: C2 – Inclusion Criteria Z-endoxifen hydrochloride Sensitive : C2	Z-endoxifen hydrochloride Sensitive: C2 – Inclusion Criteria Z-endoxifen hydrochloride Sensitive : C2
HR positive	Hormone Receptor Positive Breast Cancer	HR positive	Hormone Receptor Positive Breast Cancer	Z-endoxifen hydrochloride Sensitive: C3 – Early Trials Z-endoxifen hydrochloride Sensitive : C3	Z-endoxifen hydrochloride Sensitive: C3 – Early Trials Z-endoxifen hydrochloride Sensitive : C3